Platelet aggregation and coagulation inhibitors in leech saliva and their roles in leech therapy

Seminars in Thrombosis and Hemostasis

Volumn 22, Issue 3, 1996, Pages 273-278

  Rigbi, Meir ^b   Orevi, Miriam ^b   Eldor, Amiram ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Apyrase; Collagenase; Hirudin; Leech; PAF antagonist

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; APYRASE; BLOOD CLOTTING INHIBITOR; COLLAGEN; HIRUDIN; THROMBIN; THROMBOCYTE ACTIVATING FACTOR;

BLEEDING; HUMAN; HUMAN CELL; LEECH; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; SALIVA; SKIN FLAP; THROMBOCYTE; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0029924721     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-999019     Document Type: Review

References (69)

1. Bottenberg H: Die Blutegelbehandlung. Ein vielseitiges Verfahren der Biologischen Medizin, 2nd ed. Hippokrates-Verlag Marquardt & Cie, 1948.
2. Durand F: La renovation d'une medication desuète: Les sangsues. Arch Intern Neurol 69:17-27, 41-47, 1950.
3. Haycraft JB: On the action of a secretion obtained from the medical leech on the coagulation of the blood. Proc R Soc Lond 36:478-487, 1884.
4. Markwardt F: Hirudin as an inhibitor of thrombin. Methods Enzymol 19:924-932, 1970.
5. Bagdy D, E Barabas, L Graf: Large scale preparation of hirudin. Thromb Res 2:229-238, 1973.
6. Chang JY: The functional domain of hirudin, a thrombin-specific inhibitor. FEBS Lett 264:307-313, 1983.
7. Dodt J, HP Müller, U Seemüller, JY Chang: The complete amino acid sequence of hirudin, a thrombin specific inhibitor. FEBS Lett 165:180-184, 1984.
8. Clore GM, DR Sukumaran, M Nilges, J Zarbock, AM Gronenborn: The conformation of hirudin in solution: A study using nuclear magnetic resonance, distance geometry and restrained molecular dynamics. EMBO J 6:529-537, 1987.
9. Markwardt F, G Nowak, J Stürzebecher, U Griessbach, P Walsmann, G Vogel: Pharmacokinetics and anticoagulant effect of hirudin in man. Thromb Haemostas 52:160-163, 1984.
10. First International Symposium on Hirudin. Frankfurt A.M. 23-24 June 1989. (Abst.) Angio Arch (Munich) 18:1-104, 1989.
11. Harvey RP, E Degryse, L Stefani, F Schamber, JP Cazenave, M Courtney, P Tolstoshev, JP Lecocq: Cloning and expression of cDNA coding for the anticoagulant hirudin from the blood-sucking leech Hirudo medicinalis. Proc Natl Acad Sci USA 83:1084-1088, 1986.
12. Bergmann C, J Dodt, S Kohler, E Fink, HG Ciassen: Chemical synthesis and expression of a gene coding for hirudin, the thrombin-specific inhibitor from the leech Hirudo medicinalis. Biol Chem Hoppe-Seyler 367:731-740, 1986.
13. Dodt J, T Shmitz, T Schafer, C Bergmann: Expression, secretion and processing of hirudin in E. coli using the alkaline phosphatase signal sequence. FEBS Lett 202:373-377, 1986.
14. Stone SR, JM Maraganore: Hirudin and hirudin-based peptides. Methods Enzymol 223:312-336, 1993.
15. Linker A, K Meyer, P Hoffman: The production of hyaluronate oligosaccharides by leech hyaluronidase and alkali. J Biol Chem 235:924-927, 1960.
16. Yuki H, WH Fishman: Purification and characterization of leech hyaluronic acid - endo-β-glucuronidase. J Biol Chem 238:1877-1879, 1963.
17. Rigbi M, H Levy, F Iraqi, M Teitelbaum, M Orevi, A Alajoutsijärvi, A Horovitz, R Galun: The saliva of the medicinal leech Hirudo medicinalis: I. Biochemical characterization of the high molecular weight fraction. Comp Biochem Physiol [B] 87:567-573, 1987.
18. Seemüller U, J Dodt, E Fink, H Fritz: Proteinase inhibitors of the leech Hirudo medicinalis (hirudins, bdellins, eglins). In: Barrett AJ, G Salvesen (eds): Proteinase Inhibitors. Elsevier, Amsterdam, 1986, pp 337-352.
19. Henderson HP, B Matti, AG Laing, S Morelli, L Sully: Avulsion of the scalp treated by microvascular repair: The use of leeches for post-operative decongestion. Br J Plast Surg 36:235-239, 1983.
20. Whitlock MR, PM O'Hare, R Sanders, NC Morrow: The medicinal leech and its use in plastic surgery: A possible cause for infection. Br J Plast Surg 36:240-244, 1983.
21. Mutimer KL, JC Banis, J Upton: Microsurgical reattachment of totally amputated ears. Plast Reconstruct Surg 79:535-540, 1987.
22. Rigbi M, H Levy, A Eldor, F Iraqi, M Teitelbaum, M Orevi, A Horovitz, R Galun: The saliva of the medicinal leech Hirudo medicinalis II. Inhibition of platelet aggregation and of leukocyte activity and examination of reputed anaesthetic effects. Comp Biochem Physiol [C] 88:95-98, 1987.
23. Sawyer RT: Leech Biology and Behaviour. Oxford: Clarendon Press, 1986.
24. Orevi M, M Rigbi, A Horovitz, A Eldor: Platelet aggregation inhibitors in Hirudo medicinalis leech saliva: Partial purification and characterization by their effect on different platelet agonists. (Abst.) Blood 70(suppl. 1): 357a, 1987.
25. Baskova IP, F Misselwitz, GI Nikonov, ID Novikov, VL Leitin, VS Repin: Salivary gland secretion of the leech Hirudo medicinalis inhibits ADP-induced human platelet adhesion on a collagen coated surface. Biol Eksp Biol Med 97:696-771, 1984. (English translation by Plenum Press.)
26. Baskova IP, GI Nikonov, AV Mazurov, F Missel'vitts, VL Leitin, VS Repin, PV Avdonin, IV Svitina-Ulitina: Mechanisms of the inhibition of vascular-platelet hemostasis by salivary gland secretion of the medicinal leech Hirudo medicinalis. Biochemistry (Biokhimiya) 52:1261-1267, 1987. (Translated from Russian.)
27. Orevi M, M Rigbi, E Hy-Am, Y Matzner, A Eldor: A potent inhibitor of platelet activating factor from the saliva of the leech Hirudo medicinalis. Prostaglandins 43:483-495, 1992.
28. 1, and guanine nucleotides. J Biol Chem 254:10731-10797, 1979.
29. Cooper DMF, M Rodbell: ADP is a potent inhibitor of human platelet plasma membrane adenylate cyclase. Nature 282:515-518, 1979.
30. Law JH, Ribeiro JMC, MA Wells: Biochemical insights derived from insect diversity. Annu Rev Biochem 67:87-111, 1992.
31. Ribeiro JMC, ES Garcia: Platelet antiaggregating activity in the salivary secretion of the blood-sucking bug Rhodnius prolixus. Experientia 37:384-386, 1981.
32. Hanahan DJ: Platelet activating factor: A biologically active phosphoglyceride. Annu Rev Biochem 55:435-510, 1986.
33. Braquet P, L Touqi, TY Shen, BB Vargaftig: Perspectives in platelet-activating factor research. Pharmacol Rev 39:97-145, 1987.
34. Stewart, AG, PN Dubbin, T Harris, GJ Dusting: Platelet activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells. Proc Natl Acad Sci USA 87:3215-3219, 1990.
35. Filep J, E Foldes-Filep: Platelet-activating factors, neutrophil granulocyte function and BN52021. In: Braquet P (Ed): Gingkolides - Chemistry, Biology, Pharmacology and Clinical Perspectives. JR Prous Science Publishers, Barcelona, 1988, pp 151-159.
36. Seymour JL, WJ Henzel, B Nevins, JT Strels, RA Lazarus: Decorsin: A potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor from the leech Macrobdella decora. J Biol Chem 266:10143-10147, 1990.
37. Denis MS, WJ Henzel, RM Pitti, MT Lipari, MA Napier, TA Deisher, S Bunting, RA Lazarus: Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: Evidence for a family of platelet aggregation inhibitors. Proc Natl Acad Sci USA 87:2471-2475, 1990.
38. Electricwala A, RT Sawyer, CP Jones, T Atkinson: Isolation of a thrombin inhibitor from the leech Hirudinaria manillensis. Blood Coagul Fibrinolysis 2:83-89, 1991.
39. Strube KH, K Burkheard, S Bialojan, O Marcus, J Dodt: Isolation, sequence analysis and cloning of haemadin. J Biol Chem 268: 8590-8595, 1993.
40. Baskova IP, S Khalil, VF Nartikova, TS Pashkina: Inhibition of plasma kallikrein, kininase and kinin-like activities from preparations of medicinal leeches. Thromb Res 67:721-730, 1992.
41. Baskova IP, GI Nikonov: Destabilase, the novel ∈-(γ-Glu)-Lys isopeptidase with thrombolytic activity. Blood Coagul Fibrinolysis 2:167-172, 1992.
42. Zavalova LL, EV Kuzina, LB Levina, IP Baskova: Monomerization of fraction DD by destabilase from the medicinal leech does not alter the N-terminal sequence of the γ-chain. Thromb Res 71:241-244, 1994.
43. Loewy AG, U Santer, M Wieczorek, JK Blodgett, WS Jones, JC Cheronis: Purification and characterization of a novel zinc-proteinase from cultures of Aeromonas hydrophila. J Biol Chem 268:9071-9078, 1993.
44. Tuszynski GP, TB Gasic, GJ Gasic: Isolation and characterization of antistasin. J Biol Chem 262:9718-9723, 1987.
45. Dunwiddie C, NA Thornberry, HG Bull, M Sardana, PA Friedman, JW Jacobs, E Simpson: Antistasin, a leech-derived inhibitor of Factor Xa kinetic analysis of enzyme inhibition and identification of the reactive site. J Biol Chem 264:16694-16699, 1989.
46. Hofmann KJ, EM Nutt, CT Dunwiddie: Site-directed mutagenesis of the leech derived factor Xa inhibitor antistasin. Probing the reactive site. Biochem J 287(pt 3):943-949, 1992.
47. Manley GD, TJ Owen, JL Krstenansky, RG Brankamp, AD Cardin: Heparin binding properties of the carboxyl terminal domain of [A 103, 106, 108] antistasin 93-119. Adv Exp Med Biol 313:135-140, 1992.
48. Schreuder H, A Arkema, B de Boer, K Kalk, R Dijkema, J Mulders, H Theunissen, W Hol: Crystallization and preliminary crystallographic analysis of antistasin, a leech-derived inhibitor of blood coagulation factor Xa. J Mol Biol 231:1137-1138, 1993.
49. Dunwiddie CT, L Waxman, GP Vlasuk, PA Friedman: Purification and characterization of blood coagulation factor Xa from hematophagous organisms. Methods Enzymol 223:291-312, 1993.
50. Han JH, SW Law, PM Keller, PJ Kniskern, M Silberklang, J-S Tung, TB Gasic, GJ Gasic, PA Friedman, RW Ellis: Cloning and expression of cDNA encoding antistasin, a leech-derived protein having anti-coagulant and anti-metastatic properties. Gene 75: 47-57, 1989.
51. Hauptmann J, B Kaiser: Anticoagulant potential of synthetic and recombinant inhibitors of factor Xa and thrombin in vitro. Blood Coagul Fibrinolysis 4:577-582, 1993.
52. Rigbi M, CM Jackson, ZS Latallo: A specific inhibitor of bovine factor Xa in the saliva of the medicinal leech Hirudo medicinalis. 14th International Congress of Biochemistry. (Abst.) July 10-15, 1988, Prague.
53. Condra C, E Nutt, CJ Petraski, E Simpson, PA Friedman, JW Jacobs: Isolation and structural characterization of coagulation Factor Xa from Leech Haementeria ghilianii: Thromb Haemostas 61:437-441, 1989.
54. Söllner C, B Mentele, C Eckerskorn, H Fritz, CP Sommerhoff: Isolation and characterization of hirustasin, an antistasin-type serine-proteinase inhibitor from the medical leech Hirudo medicinalis. Eur J Biochem 219:937-943, 1994.
55. Budzynski AZ, SA Olexa, BS Brizuela, RT Sawyer, GS Stent: Anticoagulant and antifibrinolytic properties of salivary proteins from the leech Haementeria ghilianii. Proc Soc Exp Biol Med 168:266-275, 1981.
56. Gusic GJ, ED Viner, AZ Budzynski, GP Gasic. Inhibition of lung tumor colonization by leech salivary gland extracts from Haementeria ghilianii. Cancer Res 43:1633-1635, 1983.
57. Kelen EMA, G Rosenfeld: Fibrinogenolytic substance (hementerin) of Brazilian blood-sucking leeches (Haementeria lutzi Pinto [1920]). Haemostasis 4:51-64, 1975.
58. Waxman L, DE Smith, KE Arcuri, GP Vlasuk: The tick anticoagulant peptide (TAP) is a novel inhibitor of factor Xa. Science 248:593-596, 1990.
59. Jordan SP, L Waxman, DE Smith, GP Vlasuk: Tick anticoagulant peptide: kinetic analysis of recombinant inhibitor with blood coagulation factor Xa. Biochemistry 29:11095-11100, 1990.
60. Fioravanti C, D Burkholder, B Francis, PK Siegel, RE Gibson: Antithrombotic activity of recombinant tick anticoagulant peptide and heparin in a rabbit model of venous thrombosis. Thromb Res 71:317-324, 1993.
61. Jacobs JW, EW Cupp, M Sardana, PA Friedman: Isolation and characterizaiton of a coagulation factor Xa inhibitor from black fly salivary glands. Thromb Haemostas 64:235-238, 1990.
62. Parker KR, MJ Mant: Effect of tsetse salivary gland homogenate on coagulation and fibrinolysis. Thromb Haemostas 42:723-751, 1979.
63. Gordon JR, JR Allen JR: Factors V and VII anticoagulant activities in the salivary glands of feeding Dermacentor andersoni ticks. J Parasitol 77:167-170, 1991.
64. Hellman K, R Hawkins: Prolixin-S and prolixin-G: two anticoagulants from Rhodnius prolixus Stahl. Nature 207:265-267, 1965.
65. Cappelo M, LP Clyne, P McPhedran, PJ Hotez: The Ancylostoma factor Xa inhibitor: partial purification and its identification as a major hookworm-derived anticoagulant in vitro. J Infect Dis 167:1474-1477, 1993.
66. Gardell SJ, PA Friedman: Vampire bat salivary plasminogen activator. Methods Enzymol 223:233-249, 1993.
67. Seymour JL, RN Lindquist, MS Dennis, B Moffat, D Yansura, D Reilly, ME Wessinger, RA Lazarus: Ecotin is a potent anticoagulant and reversible tight binding inhibitor of Factor Xa. Biochemistry 33:3949-3958, 1994.
68. Brody GA, WJ Mahoney, VR Hentz: Digit replantation applying the leech Hirudo medicinalis. Clin Orthop 133:245-249, 1989.
69. Lineaweaver WC, MK Hill, GM Buncke, S Fallowsbee, HJ Bucke, RKM Wong, EK Manders, JC Grotting, J Anthony, SJ Mathes: Aeromonas hydrophila infections following use of medicinal leeches in replantation and flap surgery. Ann Plast Surg 29:238-244, 1992.